<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107483">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01780363</url>
  </required_header>
  <id_info>
    <org_study_id>BH-MVK</org_study_id>
    <secondary_id>CUTFBAP25011138</secondary_id>
    <secondary_id>CUTFBAP2501201138</secondary_id>
    <nct_id>NCT01780363</nct_id>
  </id_info>
  <brief_title>MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Genetics is suggested to play a critical role in the development of Behçet's
      disease (BD). Shared phenotypic features requires an approach to the differential diagnosis
      from periodic febrile syndromes particularly from mevalonate kinase deficiency related
      diseases. We planned to study for evaluating the frequency of mutations and their clinical
      significance in mevalonate kinase gene in Turkish patients with Behçet's disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Frequency of mevalonate kinase frequency in Behçet disease</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mevalonate kinase gene and clinical correlations in Behçet's disease</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <condition>Behçet's Disease</condition>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>frequency of mevalonate kinase gene frequency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behçet patients</arm_group_label>
    <description>frequency of mevalonate kinase gene mutations</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Turkish kindred
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Behçet patients

        Exclusion Criteria:

          -  Diagnosis of periodic fever syndromes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cukurova University</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Didem Arslan Tas</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <lastchanged_date>January 29, 2013</lastchanged_date>
  <firstreceived_date>January 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>Didem Arslan Tas</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Behcet Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
